Approval · Notice of Compliance 23661 · 2020
METOJECT: Notice of Compliance 23661
Issued May 22, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23661
- Date
- May 22, 2020
- Company
- Medexus Inc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Labelling Only
- Reason
- Update to Product Monograph and Package Insert
- Canadian reference product
- METHOTREXATE INJECTION USP (Mayne Pharma (Canada) Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METOJECT | Not yet assigned | — |
Medicinal ingredients
- METHOTREXATE SODIUM 10.96 MG per ML